Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention CDC Home Search CDC CDC Health Topics A-Z    
Office of Genomics and Disease Prevention  
Office of Genomics and Disease Prevention


banner

Foreword

Genomics and Population Health, 2003: Year at a Glance

Genomics Lingo…..What Do the Terms Mean?

List of Authors


I. Population Health Research

  • Chapter 1
    National Health and Nutrition Examination Survey (NHANES) III DNA Bank:
    Gene Variants Important to Public Health

    NHANES III DNA Bank • Collaborative CDC-Wide Proposal • Selecting Genetic Variants Important to Public Health • Potential Value for Public Health • Two Other CDC Projects Using NHANES III DNA Samples
  • Chapter 2
    Genomics and Acute Public Health Investigations
    What is an Acute Public Health Investigation (APHI)? • Incorporating Human Genomics into APHIs • APHI Working Group


II. Building the Evidence Base

  • Chapter 3
    Asthma Genomics: Implications for Public Health
    What Causes Asthma? • Public Health Implications of Asthma Genomics Research
    • Pharmacogenomics and Predictive Testing • Public Health Actions—Asthma Genomics Research
  • Chapter 4
    Public Health Assessment of BRCA1 and BRCA2 Testing for Breast and Ovarian Cancer
    Breast and Ovarian Cancer: An Important Public Health Problem • Genetic Tests for Breast and Ovarian Cancer Susceptibility • A Public Health Perspective • The Role of Family History in BRCA1 and BRCA2 Testing • The Role of Genetic Counseling in BRCA1 and BRCA2 Testing • Surveillance and Risk-Reducing Strategies for Breast and Ovarian Cancer
    • Evaluation of BRCA1 and BRCA2 Testing in Practice • Effectiveness of BRCA1 and BRCA2 Testing for Prevention
  • Chapter 5
    Newborn Screening for MCAD Deficiency
    What is MCADD? • Why Test Newborns for MCADD? • Tandem Mass Spectrometry Screening Test • Adding MCADD Screening to Existing Newborn Screening Programs • Is Universal Screening for MCADD Justified? • Cost-Effectiveness of Newborn MCADD Screening
    • Challenges for Implementing MCADD Screening
  • Chapter 6
    The Family History Public Health Initiative
    Family History is Valuable for Prevention • Disease Risk Due to Gene-Environment Interactions • Role of Genetic Testing • Family History and the Family Tree • The CDC Family History Initiative • Selecting Diseases to Include in a Family History Tool • Prototype Family History Tool • Data Collection • Classification • Intervention • Evaluation Studies
  • Chapter 7
    Genetic Testing and the Prevention of Coronary Heart Disease: A Case Study
    Will a Genomic Profile Help Prevent Coronary Heart Disease (CHD)? • Is Genomic Profiling for CHD Ready for Prime Time? • Medical Family History as Genomic Profiling • Family History is Still the Best Genomic Tool • Guidelines for CHD Prevention
  • Chapter 8
    Genomics and Public Health: Ethical, Legal, and Social Issues
    Ethical, Legal, and Social Issues (ELSI) • Public Health Ethical Legal, and Social Issues (PHELSI) • Is PHELSI Different from ELSI? • Public Health Ethics • Ethical Issues in Public Health Genomics • Legal Issues in Public Health Genomics • Social Issues in Public Health Genomics • Engagement and Education to Address PHELSI • A Genetic Agenda for Public Health


III. Genomics in Practice

  • Chapter 9
    Carrier Testing for Cystic Fibrosis: Transition from Research to Clinical Practice
    About Cystic Fibrosis • CFTR: The CF Gene • Cystic Fibrosis Carrier Testing • History of CF Testing in the United States • CF Testing in the United States: Transition from Research to Clinical Practice • Evaluation of Prenatal CF Screening • 2003: Learning from Implementation and Practice • Public Health Importance of Lessons Learned
  • Chapter 10
    Ensuring the Quality of Genetic Testing in the United States
    Why is the Quality of Genetic Testing Important to Public Health? • Genetic Testing Issues • Who Considers These Issues in the United States? • What Oversight Currently Exists for Genetic Testing? • “Home Brew” Genetic Tests and the FDA • How Do States Regulate Genetic Testing? • What Private Sector Organizations Are Concerned with Genetic Testing? • What is Needed to Ensure the Safety of Genetic Testing? • How is CDC Addressing These Needs?
  • Chapter 11
    Hemochromatosis: Information and Resources for Health Care Providers
    What is Hemochromatosis? • Why is Hemochromatosis a Public Health Problem? • Is Population Screening Recommended for Hemochromatosis? • CDC’S Online Training on Hemochromatosis for Health Care Providers
  • Chapter 12
    Genomics Training for Public Health Practice: The Michigan Experience
    Why Does the Public Health Workforce Need Genomics Training? • What Has Been Done to Develop Genomics Training? • Simple Training Strategies and Available Courses • Strategy 1: Building a Foundation—Know Your Audience • Strategy 2: Raising Awareness and Stimulating Interest • Strategy 3: Increasing Knowledge • Strategy 4: Strengthening Skills
    • Strategy 5: Using Evaluation to Improve Training • Lessons Learned
  • Chapter 13
    Genomics Tools for Public Health
    What are Genomic Tools? • Genomic Tools in Practice and the Genomics Toolkit • Genomic Tools We Need, But Don’t Currently Have • How Will New Tools Be Developed? • Thinking Genomically—the Vision for the Future
  • Chapter 14
    State Capacity Grants for Integrating Genomics into Chronic Disease Prevention Programs
    Michigan, Minnesota, Oregon and Utah Genomics and Chronic Disease Prevention Programs • Michigan • Minnesota • Oregon • Utah • Next Steps
  • Chapter 15
    Internet Resources for Genomics and Disease Prevention
    CDC Office of Genomics and Disease Prevention (OGDP) • Human Genome Project
    • Genomic Research • Genetic Testing • Family History • Genes and Diseases • Cancer
    • Birth Defects • Newborn Screening • Public Health Ethical, Legal, and Social Issues (PHELSI) • Policy • Public Health Resources • Educational Resources





arrow Cover
arrow Table of Contents
arrow Foreword
arrow Year at a Glance
arrow Genomics Lingo
arrow List of Authors
-------------------
arrow Chapter 1
arrow Chapter 2
arrow Chapter 3
arrow Chapter 4
arrow Chapter 5
arrow Chapter 6
arrow Chapter 7
arrow Chapter 8
arrow Chapter 9
arrow Chapter 10
arrow Chapter 11
arrow Chapter 12
arrow Chapter 13
arrow Chapter 14
arrow Chapter 15
-------------------
arrow Email comments to brj9@cdc.gov
Last Updated August 13, 2004